– Administered FVIII 100 IU/kg BID
– Laboratory assessment of FVIII activity and inhibitor done every 2 weeks
– Acute bleeding episodes treated PRN with bypassing product
| Treatment Course | |
| Follow up | Outcome |
| 1 month | Inhibitor 4 BU, continue FVIII infusion BID |
| 3 months | Inhibitor 3 BU, continue FVIII infusion BID |
| 5 months | Inhibitor 1 BU, change FVIII infusion to QD |
| 6 months | Inhibitor undetected, change FVIII infusion to QOD |
| 12 months | Inhibitor still undetectable, On 3 times/week infusion |